PARTILLION BIOSCIENCE CORP
Unlocking Functional Single-Cell Biology
Los Angeles, United States · Founded 2021 · $5.0M raised
- Headquarters
- Los Angeles, California
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- partillion.com
- Total Funding
- $5.0M
- Last Round
- $5.0M SeedSep 2023
- Rounds
- 1
About
Partillion Bioscience is a functional single-cell biology company offering the world's first functional single-cell reagent platform based on hydrogel Nanovial technology. Their platform enables high-throughput screening of cells by secretion and transcriptomic profiling without new equipment, supporting applications in antibody discovery, CAR-T cell therapy development, and immunotherapy research.
Summary
PARTILLION BIOSCIENCE CORP is a Biotech company based in Los Angeles, United States, founded in 2021. It has raised $5.0M in total across 1 round, most recently a $5.0M Seed round in Sep 2023. Investors include ND Capital, Vertical Venture Partners and Paladin Capital Group.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2023
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company